Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Zhichu Xiang"'
Publikováno v:
Advanced Science, Vol 11, Iss 33, Pp n/a-n/a (2024)
Abstract Detection of circulating tumor DNA (ctDNA) mutations, which are molecular biomarkers present in bodily fluids of cancer patients, can be applied for tumor diagnosis and prognosis monitoring. However, current profiling of ctDNA mutations reli
Externí odkaz:
https://doaj.org/article/092506233c6b476c9698e61e5d3d6b2f
Publikováno v:
Applied Sciences, Vol 11, Iss 20, p 9541 (2021)
Biocompatible nanosystems based on polymeric materials are promising drug delivery nanocarrier candidates for antitumor therapy. However, the efficacy is unsatisfying due to nonspecific accumulation and drug release of the nanoparticles in normal tis
Externí odkaz:
https://doaj.org/article/11ce9615c6f94b32a49cf8af39d8f2a5
Autor:
Xiaoliang Yang, Zihua Wang, Zhichu Xiang, Dan Li, Zhiyuan Hu, Wei Cui, Lingling Geng, Qiaojun Fang
Publikováno v:
PLoS Computational Biology, Vol 13, Iss 4, p e1005441 (2017)
A high level of HER2 expression in breast cancer correlates with a higher tumor growth rate, high metastatic potential, and a poor long-term patient survival rate. Pertuzumab, a human monoclonal antibody, can reduce the effect of HER2 overexpression
Externí odkaz:
https://doaj.org/article/454c09050465481aab284dcced9e9726
Autor:
Zhichu Xiang, Gexuan Jiang, Xiaoliang Yang, Di Fan, Xiaohui Nan, Dan Li, Zhiyuan Hu, Qiaojun Fang
Publikováno v:
Biomolecules, Vol 9, Iss 5, p 172 (2019)
Improving the efficacy of nanoparticles (NPs) delivery to tumors is critical for cancer diagnosis and therapy. In our previous work, amphiphilic peptide APPA self-assembled nanocarriers were designed and constructed for cargo delivery to tumors with
Externí odkaz:
https://doaj.org/article/3c8eb0206f014634930c9b18824d6e72
Autor:
Zhichu Xiang, Jianhua Lu, Shangrui Rao, Chenxing Fu, Yuying Yao, Yongdong Yi, Yang Ming, Weijian Sun, Weisheng Guo, Xiaoyuan Chen
Publikováno v:
Theranostics; 2024, Vol. 14 Issue 6, p2290-2303, 14p
Publikováno v:
SCIENTIA SINICA Chimica. 52:1592-1600
Publikováno v:
Nanoscale Horizons; Aug2023, Vol. 8 Issue 8, p1062-1072, 11p
Publikováno v:
Biochimie. 189:65-75
Breast cancer is the most common and highly heterogeneous disease in women worldwide. Given the challenges in the treatment of advanced metastatic breast cancer, it is necessary to understand the molecular mechanisms related to disease progression. E
Publikováno v:
Angewandte Chemie International Edition. 60:22659-22663
Protease-triggered control of functional DNA has remained unachieved, leaving a significant gap in activatable DNA biotechnology. Herein, we report the design of a protease-activatable aptamer system that can perform molecular sensing and imaging in
Publikováno v:
Advanced healthcare materials. 11(14)
Nanomaterials as T